Baylor Research Institute

Mohammad Shahzeb Khan

22 May 2026reporter.nih.gov

NCT07547878

Phase 4Not yet recruiting202664 people23 Apr 2026clinicaltrials.gov

NCT06517212

Phase 2Recruiting202448 people24 Jul 2024clinicaltrials.gov

NCT04926467

Phase 2Recruiting202124 people15 Jun 2021clinicaltrials.gov

NCT03480568

Phase 3Recruiting201820 people29 Mar 2018clinicaltrials.gov

NCT02724202

Early phase 1Terminated201815 people31 Mar 2016clinicaltrials.gov

NCT02554344

Early phase 1Withdrawn20150 people18 Sept 2015clinicaltrials.gov

NCT02550327

Early phase 1Completed201620 people15 Sept 2015clinicaltrials.gov

NCT02251431

Phase 3Completed201557 people29 Sept 2014clinicaltrials.gov

NCT02081755

Phase 4Enrolling by invitation2014336 people7 Mar 2014clinicaltrials.gov

NCT02021422

Phase 1Completed201313 people27 Dec 2013clinicaltrials.gov

NCT01802970

Phase 1Completed201210 people4 Mar 2013clinicaltrials.gov

National Institute of Diabetes and Digestive and Kidney Diseases

R01A Pilot Randomized Clinical Trial to Assess Feasibility, Safety, and Efficacy of Rapid, Simultaneous Therapy Initiation in Chronic Kidney Disease and Type 2 Diabetes: RAPID-CKDR01DK147678US$306.4k2026–202922 May 2026reporter.nih.gov